A detailed history of Bank Of America Corp transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 820 shares of SNTI stock, worth $1,795. This represents 0.0% of its overall portfolio holdings.

Number of Shares
820
Previous 241 240.25%
Holding current value
$1,795
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.24 - $0.4 $138 - $231
579 Added 240.25%
820 $0
Q1 2024

May 15, 2024

SELL
$0.36 - $0.66 $1,800 - $3,300
-5,000 Reduced 95.4%
241 $0
Q4 2023

Feb 14, 2024

BUY
$0.28 - $0.68 $1,408 - $3,419
5,029 Added 2372.17%
5,241 $3,000
Q2 2023

Aug 14, 2023

BUY
$0.6 - $1.14 $127 - $241
212 New
212 $0
Q4 2022

Feb 10, 2023

SELL
$1.25 - $65.2 $17,870 - $932,099
-14,296 Reduced 99.86%
20 $0
Q3 2022

Nov 14, 2022

BUY
$1.33 - $21.7 $14 - $238
11 Added 0.08%
14,316 $31,000
Q2 2022

Aug 12, 2022

BUY
$1.97 - $10.0 $28,180 - $143,050
14,305 New
14,305 $28,000

Others Institutions Holding SNTI

About Senti Biosciences, Inc.


  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $95.8M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.